Page last updated: 2024-09-04

conivaptan and Acquired Nephrogenic Diabetes Insipidus

conivaptan has been researched along with Acquired Nephrogenic Diabetes Insipidus in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arthus, MF; Bernier, V; Bichet, DG; Bouvier, M; Brouard, R; Debrand, N; Laperrière, A; Lonergan, M; Morello, JP; Salahpour, A; Zarruk, A1
Greenberg, A; Verbalis, JG1

Reviews

1 review(s) available for conivaptan and Acquired Nephrogenic Diabetes Insipidus

ArticleYear
Vasopressin receptor antagonists.
    Kidney international, 2006, Volume: 69, Issue:12

    Topics: Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Clinical Trials as Topic; Diabetes Insipidus, Nephrogenic; Fibrosis; Heart Failure; Humans; Hyponatremia; Osmolar Concentration; Polycystic Kidney Diseases; Pyrroles; Receptors, Vasopressin; Sodium; Tolvaptan; United States; United States Food and Drug Administration; Vasopressins

2006

Other Studies

1 other study(ies) available for conivaptan and Acquired Nephrogenic Diabetes Insipidus

ArticleYear
Pharmacologic chaperones as a potential treatment for X-linked nephrogenic diabetes insipidus.
    Journal of the American Society of Nephrology : JASN, 2006, Volume: 17, Issue:1

    Topics: Adult; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cells, Cultured; Chromosomes, Human, X; Diabetes Insipidus, Nephrogenic; Genetic Linkage; Humans; Indoles; Male; Mutation; Pyrrolidines; Receptors, Vasopressin

2006